Need help?

EN ISO 10993-17:2023 Standard

wave
Save  

  Keywords:

#chemical #described #process #exposure #apply

This standard can be totally or partially supervised by:
  •   EN ISO 10993-17:2023/A1:2025
  •   Directive

    Medical devices Regulation ((EU) 2017/745)

      Last Official Journal reference

    Thursday 11th of June 2026

      Description:

    Biological evaluation of medical devices - Part 17: Toxicological risk assessment of medical device constituents (ISO 10993-17:2023)

      Purpose

    ISO 10993-17 specifies the process and requirements for the toxicological risk assessment of medical device constituents to be used in the final product's biological evaluation (described in ISO 10993-1). It includes the methods and criteria used to assess if exposure to a chemical constituent is without appreciable harm.The process described in this standard is intended to apply after chemical characterization compositional profiling is performed as required by ISO 10993-18. Thus a toxicological risk assessment of either the compositional information, extractable data or leachable data is required to conclude if the risks related to the constituents are acceptable or not.The process described in ISO 10993-17 is not intended to apply to circumstances where the toxicological risk has been estimated by other means, such as:— constituents, excluding cohort of concern or excluded chemicals, that are present or extracted at an amount representative of patient exposure below a relevant, toxicologically-based reporting threshold.— a new or changed medical device for which chemical or biological equivalence has been established with an existing biocompatible or clinically established medical device.The process described in ISO 10993-17 is also not applicable to:— medical device constituents that do not contact the body,— all biological risks applicable to a medical device provided that the chemical exposure is unchanged,— active pharmaceutical ingredients of device-drug combination products or biologic components of device-biologic combination products as additional regulatory considerations may apply,— exposure to a particular chemical constituent that arises from sources other than the device, such as food, water, or air.The text of ISO 10993-17:2023 has been approved in Europe as EN ISO 10993-17:2023 without any changes.

      Publication

    Friday 8th of March 2024

      Cessation

    This standard will be withdrawn on 2027-12-15

      Related Standards

    EN 60601-1:2006

    Medical devices Regulation ((EU) 2017/745)

    Medical electrical equipment - Part 1: General requirements for basic safety and essential performance

    EN ISO 11737-2:2020

    Medical devices Regulation ((EU) 2017/745)

    Sterilization of health care products - Microbiological methods - Part 2: Tests of sterility performed in the definition, validati...

    EN ISO 14155:2020

    Medical devices Regulation ((EU) 2017/745)

    Clinical investigation of medical devices for human subjects - Good clinical practice (ISO 14155:2020)

    EN ISO 7197:2024

    Medical devices Regulation ((EU) 2017/745)

    Neurosurgical implants - Sterile, single-use hydrocephalus shunts (ISO 7197:2024)

    EN 14180:2025

    Medical devices Regulation ((EU) 2017/745)

    Sterilizers for medical purposes - Low temperature steam and formaldehyde sterilizers - Requirements and testing

    EN 13795-2:2025

    Medical devices Regulation ((EU) 2017/745)

    Surgical clothing and drapes - Requirements and test methods - Part 2: Clean air suits

      Stay up to date

      ACCESS

    Search for a standard
    GO

    Register

    Already a member?
    Login

      OTHER APPLICATIONS

    If you are interested in DO160 tests, you can give a try to our other free of charge software:
    CE-Marking assistant, Version: 1.3.0